Welcome to Labeled Immunoassays and Clinical Medicine website!
Orignal Article

Clinical Significance of Combined Detection of Serum Tumor Markers in Patients with Pulmonary Cancer

  • WANG Lei ,
  • HE Jie ,
  • YAO Yong ,
  • ZHANG Yuanying ,
  • YAN Baoxin ,
  • XI Yanchun ,
  • DONG Lin
Expand
  • Department of Nuclear Medicine,Shijingshan Hospital,Capital Medical University,Beijing 10043, China

Received date: 2012-10-09

  Online published: 2013-08-20

Abstract

To explore the significance of five serum tumor markers(TM) detection in the diagnosis of lung cancer. Methods The serum levels of NSE, CYFRA 211, CEA, CA125 and SCC were detected with IRMA and ELISA in 73 patients with lung cancer, 22 patients with lung benign diseases and 25 healthy people. Results The serum levels of the five TMs in patients with lung cancer were significantly higher than that of in patients with lung benign diseases and healthy people(P<0.01). Although the five TMs levels in patients with lung benign diseases were slightly higher than that of healthy people, it was no statistical significance(P>0.05).The sensitivity of NSE, CYFRA 211, CEA, SCC and CA125 in patients with lung cancer were 45.20%,41.09%,34.24%,53.42%,38.35%,and the specificity of that were 80.85%,78.72%,80.85%,82.98%,74.47%.The sensitivity and specificity of five TMs combined detection were 93.15% and 44.68% respectively. Conclusion The combined detection of five TMs is useful in the diagnosis of lung cancer. The reasonable combined detection can improve the diagnostic sensitivity and the detection rate of lung cancer.

Cite this article

WANG Lei , HE Jie , YAO Yong , ZHANG Yuanying , YAN Baoxin , XI Yanchun , DONG Lin . Clinical Significance of Combined Detection of Serum Tumor Markers in Patients with Pulmonary Cancer[J]. Labeled Immunoassays and Clinical Medicine, 2013 , 20(3) : 140 -141 . DOI: 10.11748/bjmy.issn.1006-1703.2013.03.005

References

[1] Bach P B. Smoking as a factor in causing lung cancer[J].JAMA, 2009,301(5):539541.
[2] 陈梅,周静,陈绪元.肿瘤标志物检测在肺小细胞肺癌放化疗中的临床意义[J].第四军医大学学报,2009,30:15121514.
[3] Schneider J, Velcovsky H G, Morr H, et al. Comparison of the tumor markers tumor M2PK,CEA,CYFRA211,NSE and SCC in the diagnosis of lung cancer[J].Anticancer Res,2000,20(6D):50535058.
[4] Okada M,Sakamoto T,Nishio W,et al. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension[J].Cancer,2003,98(3):535541.
[5] 刘延峰,杨栓盈.CYFRA211对早期肺小细胞肺癌诊断价值的Meta分析[J].西安交通大学学报:医学版,2011,32(1):3437.
[6] 刘明军,刘自民.肺癌肿瘤标志物的临床应用与研究进展[J].医学综述,2011,17(22):34093411.
[7] Diez M, Cerdan F J, Ortega M D, et al. Evaluation of serum CA125 as a tumor marker in nonsmall cell lung cancer[J].Cancer,1991,67(21):150154.
[8] Kimura Y, Fujii T. Serum CA125 level is a good prognostic indicator in lung cancer[J].Cancer,1990,62(19):676678.
[9] 赵传军.晚期非小细胞肺癌患者血清CA125水平的预后价值[J].中国中医药现代远程教育,2010,8(23):103.
[10] Polberg K, Stepulak A, Zawislak J,et al. Squamous cell carcinoma antigen levels in patients with laryngeal cancer[J]. Pol Merkur Lekarski, 2005,19:375376.
Outlines

/